% Expired Patents = 55.6

EPO Patents = 3

Forward Citations = 64

Loading Chart...

4 inventors (with patents filed for the assignee):

Jeffrey M Greve (9 out of 40 patents)

Niranjana Aditi Nagarajan (2 out of 4 patents)

Jungmin Kim (2 out of 2 patents)

4. John Cho (2 out of 2 patents)

9 patents: Sort by Forward Citations

1. 11535657 - Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases (2022-12-27),

2. 11077172 - IL-2 variants for the treatment of psoriasis (2021-08-03),

3. 11059877 - Multivalent regulatory T cell modulators (2021-07-13),

4. 10875901 - Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases (2020-12-29),

5. 10774126 - Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases (2020-09-15),

6. 10766938 - Nucleic acid encoding human IL-2 variant (2020-09-08),

7. 10472405 - Multivalent regulatory T cell modulators (2019-11-12),

8. 10294287 - Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases (2019-05-21),

9. 10035836 - Modified IL-2 variants that selectively activate regulatory T cells (2018-07-31),

Company Overview

Delinia, Inc. is a biotechnology company focused on developing novel treatments for autoimmune diseases. Our proprietary technology platform harnesses the power of the immune system to create personalized therapies for patients. With a team of experienced scientists and experts, Delinia is at the forefront of advancing precision medicine in the field of autoimmune diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#55 in Emeryville, CA

#7,735 in California

#32,588 in US

Emeryville, CA, United States of America

Delinia, Inc.

Forward Citations = 64

4 inventors:

Jeffrey M Greve (9 out of 40 patents)

Niranjana Aditi Nagarajan (2 out of 4 patents)

Jungmin Kim (2 out of 2 patents)

4. John Cho (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Delinia, Inc.. Retrieved from https://idiyas.com/company/delinia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]